ABALOPARATIDE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 11 adverse event reports in the FDA FAERS database where ABALOPARATIDE was used for Psoriasis.
Most Reported Side Effects for ABALOPARATIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 4,048 | 17.3% | 0 | 92 |
| Nausea | 3,134 | 13.4% | 1 | 84 |
| Dizziness | 3,005 | 12.9% | 0 | 99 |
| Fatigue | 2,637 | 11.3% | 0 | 63 |
| Heart rate increased | 2,092 | 9.0% | 0 | 40 |
| Palpitations | 1,730 | 7.4% | 0 | 50 |
| Arthralgia | 1,711 | 7.3% | 0 | 41 |
| Bone pain | 1,360 | 5.8% | 0 | 26 |
| Back pain | 1,229 | 5.3% | 0 | 37 |
| Pain | 1,191 | 5.1% | 0 | 48 |
| Product dose omission issue | 1,006 | 4.3% | 0 | 78 |
| Injection site bruising | 946 | 4.1% | 0 | 20 |
| Product dose omission | 938 | 4.0% | 1 | 64 |
| Product quality issue | 914 | 3.9% | 1 | 26 |
| Pain in extremity | 912 | 3.9% | 0 | 26 |
Other Indications for ABALOPARATIDE
Osteoporosis postmenopausal (7,932)
Senile osteoporosis (7,272)
Osteoporosis (4,420)
Product used for unknown indication (3,174)
Osteoporotic fracture (658)
Pathological fracture (191)
Illness (179)
Rheumatoid arthritis (130)
Osteoarthritis (71)
Bone density abnormal (70)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)